Please assess the completion status of the following clinical trial:

Trial Title: IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: OTHER
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Parents or legally authorized representatives must give signed informed consent before any Registry-related activities are conducted. Assent from the subject should also be obtained where appropriate.~* Patients receiving Increlex® by a qualified practitioner may be enrolled~Exclusion Criteria:

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Increlex patients (Type: None): Eligible patients will be patients beginning therapy with Increlex® or those previously treated with Increlex.

Based on this trial design, predict the completion outcome and termination type (if applicable).